Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Sees Large Increase in Short Interest

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 283,300 shares, an increase of 113.3% from the December 15th total of 132,800 shares. Based on an average daily trading volume, of 128,139,400 shares, the short-interest ratio is presently 0.0 days.

Therapeutic Solutions International Stock Performance

TSOI traded up $0.00 during midday trading on Thursday, hitting $0.00. The company had a trading volume of 131,410,234 shares, compared to its average volume of 74,971,563. Therapeutic Solutions International has a twelve month low of $0.00 and a twelve month high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.